Case study: treatment-resistant schizophrenia - The Pharmaceutical Journal
Frontiers | Treatment-Resistant Schizophrenia: Genetic and Neuroimaging Correlates
Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review - ScienceDirect
Meta-analysis of randomised controlled trials with N-acetylcysteine in the treatment of schizophrenia - Caitlin OB Yolland, Donal Hanratty, Erica Neill, Susan L Rossell, Michael Berk, Olivia M Dean, David J Castle, Eric
Meta-analysis of randomised controlled trials with N-acetylcysteine in the treatment of schizophrenia - Caitlin OB Yolland, Donal Hanratty, Erica Neill, Susan L Rossell, Michael Berk, Olivia M Dean, David J Castle, Eric
PDF) N -Acetylcysteine (NAC) in Schizophrenia Resistant to Clozapine: A Double-Blind, Randomized, Placebo-Controlled Trial Targeting Negative Symptoms
Targets for Drug Therapy for Autism Spectrum Disorder: Challenges and Future Directions | Journal of Medicinal Chemistry
Antipsychotic-induced sensitization and tolerance: Behavioral characteristics, developmental impacts, and neurobiological mechanisms - Ming Li, 2016
Meta-analysis of randomised controlled trials with N-acetylcysteine in the treatment of schizophrenia - Caitlin OB Yolland, Donal Hanratty, Erica Neill, Susan L Rossell, Michael Berk, Olivia M Dean, David J Castle, Eric
Vicks Drug of Choice List | PDF | Enzyme Inhibitor | Nonsteroidal Anti Inflammatory Drug
Cannabinoid Receptor Subtype 2 (CB2R) in a Multitarget Approach: Perspective of an Innovative Strategy in Cancer and Neurodegeneration | Journal of Medicinal Chemistry
PDF) Strategies in clozapine-resistant schizophrenia: A literature review
PDF) Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology
Meta-analysis of randomised controlled trials with N-acetylcysteine in the treatment of schizophrenia - Caitlin OB Yolland, Donal Hanratty, Erica Neill, Susan L Rossell, Michael Berk, Olivia M Dean, David J Castle, Eric
Pharmacokinetic simulations comparing acetylcysteine concentrations vs.... | Download Scientific Diagram
21st ISoP Annual Meeting “A New Era of Pharmacovigilance: Challenges and Opportunities” 20–23 September 2022 Verona, Italy | SpringerLink
PDF) N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: A double blind randomised placebo controlled trial targeting negative symptoms
Predictors of treatment resistance in patients with schizophrenia: a population-based cohort study - The Lancet Psychiatry
Effect of single dose N-acetylcysteine administration on resting state functional connectivity in schizophrenia | SpringerLink
Treatment-Resistant Schizophrenia Guideline | Psychiatrist.com
Geneesmiddelengebruik in de belgische rusthuizen en rust ... - KCE
Annual Report 2008 - Istituto di Ricerche Farmacologiche Mario Negri
Criteria indicating treatment-resistant schizophrenia, and proxy... | Download Scientific Diagram
